State of Bio with latest news





Another day, another slice of the business being sold. What's next?
It is not a cosmic puzzle. We all know what the end objective is. They should have never purchased Bio to begin with. Grodman sold them a bag of tainted goods. Piecemealing to satisfy FTC guidelines. Gradually divesting before a sale is often referred to as a phased divestment. Buyer approval is the end game. The FTC may impose conditions to monitor the divestiture process, ensuring compliance and preventing anti-competitive practices. Then, Bye-Bye.
 



It is not a cosmic puzzle. We all know what the end objective is. They should have never purchased Bio to begin with. Grodman sold them a bag of tainted goods. Piecemealing to satisfy FTC guidelines. Gradually divesting before a sale is often referred to as a phased divestment. Buyer approval is the end game. The FTC may impose conditions to monitor the divestiture process, ensuring compliance and preventing anti-competitive practices. Then, Bye-Bye.
You sound like you know what you are talking about, and you're probably spot on. Maybe another year or two at most...
 





















Only LC, Q & Sonic labs (and a handful of molecular labs) are turning profits. All labs are either breaking even or losing money. Reimbursements are too low and costs are too high.If mergers don't happen with the smaller labs ASAP, the big 3 will be the only labs standing in 1-2 years!